While the ablation of Cav1 leads to molecular and cellular changes in mice that are the hallmarks of Alzheimer’s disease [18,41], the role of Aplp2 in neurodegeneration in mice is not known. This evidence concerns the gene APLP2 and early-onset autosomal dominant Alzheimer disease.